|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
52624.29 Cr.
|
P/BV
|
21.01
|
Book Value (Rs.)
|
147.85
|
|
52 Week High/Low (Rs.)
|
3121/2088
|
FV/ML
|
10/1
|
P/E(X)
|
50.80
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
61.15
|
Div Yield (%)
|
1.83
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 61.15 | 54.52 | 41.14 | 36.08 | 99.29 |
| Diluted EPS (Rs.) | 61.15 | 54.76 | 34.83 | 36.05 | 100.04 |
| Cash EPS (Rs.) | 65.08 | 58.70 | 38.94 | 39.93 | 104.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 133.85 | 115.19 | 104.93 | 102.79 | 157.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 133.85 | 115.19 | 104.93 | 102.79 | 157.19 |
| Revenue From Operations / Share (Rs.) | 225.59 | 221.32 | 203.87 | 191.95 | 193.50 |
| PBDIT / Share (Rs.) | 85.86 | 78.11 | 60.88 | 53.42 | 49.45 |
| PBIT / Share (Rs.) | 81.94 | 74.17 | 56.76 | 49.54 | 45.42 |
| PBT / Share (Rs.) | 83.00 | 74.37 | 48.18 | 49.37 | 45.99 |
| Net Profit / Share (Rs.) | 61.15 | 54.76 | 34.83 | 36.05 | 100.04 |
| NP After MI And SOA / Share (Rs.) | 61.15 | 54.91 | 35.07 | 36.41 | 100.04 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 38.06 | 35.29 | 29.86 | 27.82 | 25.55 |
| PBIT Margin (%) | 36.32 | 33.51 | 27.84 | 25.80 | 23.47 |
| PBT Margin (%) | 36.79 | 33.60 | 23.63 | 25.72 | 23.76 |
| Net Profit Margin (%) | 27.10 | 24.74 | 17.08 | 18.78 | 51.69 |
| NP After MI And SOA Margin (%) | 27.10 | 24.81 | 17.20 | 18.96 | 51.69 |
| Return on Networth / Equity (%) | 45.68 | 47.67 | 33.42 | 35.41 | 63.64 |
| Return on Capital Employeed (%) | 54.54 | 57.03 | 47.33 | 41.95 | 26.21 |
| Return On Assets (%) | 23.95 | 22.64 | 16.70 | 18.53 | 36.57 |
| Asset Turnover Ratio (%) | 0.90 | 0.97 | 1.00 | 0.80 | 0.83 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.03 | 1.79 | 1.84 | 1.88 | 2.18 |
| Quick Ratio (X) | 1.77 | 1.54 | 1.49 | 1.53 | 1.87 |
| Inventory Turnover Ratio (X) | 8.14 | 7.45 | 1.11 | 0.81 | 1.04 |
| Dividend Payout Ratio (NP) (%) | 68.67 | 80.12 | 91.24 | 247.21 | 29.98 |
| Dividend Payout Ratio (CP) (%) | 64.53 | 74.76 | 81.66 | 223.39 | 28.82 |
| Earning Retention Ratio (%) | 31.33 | 19.88 | 8.76 | -147.21 | 70.02 |
| Cash Earning Retention Ratio (%) | 35.47 | 25.24 | 18.34 | -123.39 | 71.18 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 532.36 | 1007.30 | 573.35 | 499.36 | 419.65 |
| Interest Coverage Ratio (Post Tax) (%) | 372.61 | 703.51 | 408.84 | 336.84 | 185.96 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 37291.15 | 47339.67 | 31854.06 | 21275.97 | 25686.86 |
| EV / Net Operating Revenue (X) | 9.76 | 12.63 | 9.22 | 6.54 | 7.84 |
| EV / EBITDA (X) | 25.64 | 35.77 | 30.89 | 23.51 | 30.67 |
| MarketCap / Net Operating Revenue (X) | 10.12 | 13.00 | 9.53 | 6.90 | 8.59 |
| Retention Ratios (%) | 31.32 | 19.87 | 8.75 | -147.21 | 70.01 |
| Price / BV (X) | 17.06 | 24.98 | 18.52 | 12.88 | 10.58 |
| Price / Net Operating Revenue (X) | 10.12 | 13.00 | 9.53 | 6.90 | 8.59 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.06 |
